The legacy status of Viagra, and the parent firm copyright, presents a intriguing question for investors . While earnings initially soared , the impending patent expiration and growing generic rivalry https://phoebeydoi030216.ambien-blog.com/48390179/the-blue-pill-and-the-pharmaceutical-industry-a-uncertain-investment